In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer.
about
Genetic variation in the progesterone receptor gene and ovarian cancer risk.Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesisHER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients.Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.Tissue biomarkers in prognostication of serous ovarian cancer following neoadjuvant chemotherapy.Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors.Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.Ovarian clear cell adenocarcinoma: a continuing enigmaId-I stimulates cell proliferation through activation of EGFR in ovarian cancer cellsMechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.Genomic analysis of epithelial ovarian cancer.Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancerTargeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients.Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.
P2860
Q24540482-222BDDFB-1A79-4931-8C98-B5C2DDBA4298Q28272119-E52DD469-1C35-4532-921E-A52B9B2A37B2Q33305210-28A3AA44-C6E2-4C02-987A-7F7414A77553Q33365433-333D71A1-A83A-41F6-AD81-6AB923C7BCB8Q33594110-F4780108-5345-408F-B65C-0BFD021D461FQ33739577-7FAEA314-E26F-4A99-961E-5EB21EA83FA8Q34517743-6CE8F784-3704-4461-BFC6-FEA4B18D23F7Q36026090-B5FFC631-1EEF-429F-B0E8-6D9E0963A4BAQ36695270-E7706E9C-EBC4-429B-A36B-5F611E1454A5Q37123500-B8733A21-1F44-465C-A2B1-7BAB48D90579Q37144104-BF8E7CB4-F5BF-47BC-AE67-0AC4B6719292Q37248561-9DE8F996-162F-4181-82C2-973E0A5FCECAQ37485865-964D0AA9-6B86-4D71-B955-EBCF399E2B79Q47965726-F949E026-3160-4E43-9713-CD4A73CE3394Q52643559-8F011750-B0C3-48EF-9AA1-A79FD3BC5B2B
P2860
In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
In vitro chemoresistance and b ...... of epithelial ovarian cancer.
@en
In vitro chemoresistance and b ...... of epithelial ovarian cancer.
@nl
type
label
In vitro chemoresistance and b ...... of epithelial ovarian cancer.
@en
In vitro chemoresistance and b ...... of epithelial ovarian cancer.
@nl
prefLabel
In vitro chemoresistance and b ...... of epithelial ovarian cancer.
@en
In vitro chemoresistance and b ...... of epithelial ovarian cancer.
@nl
P2093
P1433
P1476
In vitro chemoresistance and b ...... of epithelial ovarian cancer.
@en
P2093
Ainura Kyshtoobayeva
John P Fruehauf
Noelle Gillette Cloven
Robert A Burger
P304
P356
10.1016/J.YGYNO.2003.09.030
P407
P577
2004-01-01T00:00:00Z